Evaluation of T320, an Anti-Tissue Factor Antibody-Drug Conjugate, in Patients With Advanced Solid Tumors

NCT07434609 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor (Phase 1)

Interventions

BIOLOGICAL: T320 for Injection

Sponsor

Nanolattix Biotechnology Co., Ltd.